Innovative analytical technologies for biopharmaceuticals
The Dutch Foundation for Technical Sciences (STW) has granted about EUR 1.5 million to the following groups: Analytical Biochemistry at the University of Groningen (Prof. R. Bischoff), Biomedical Analysis at Utrecht University (Prof. G.J. de Jong) and Biomolecular Analysis at the VU University Amsterdam (Prof. H. Irth and Prof. W.M.A. Niessen). They will be cooperating in this project with Prof. W.J. Quax (Pharmaceutical Biology, University of Groningen) and Prof. M.J. Smit (Receptor Biochemistry and Medicinal Chemistry, VU). Moreover, different companies will support this project with a total contribution of about EUR 0.8 million.
The development of biopharmaceuticals (pharmaceutical proteins) is crucial for the pharmaceutical and biotechnological industry as breakthroughs are expected from these types of products. Insulin is the most well-known pharmaceutical protein and has been used successfully for many years. Monoclonal antibodies, which are also produced in cell cultures, are particularly promising for the treatment of certain forms of cancer. Other modern biopharmaceuticals are human growth hormone and cytokines such as interferons. These proteins have very complex structures and require new technologies for their analysis. This collaborative project aims at developing such techniques for the screening of new receptor agonists and antagonists, for the analysis of biological samples to study the fate of biopharmaceuticals in the body and for the characterization of pharmaceutical proteins (heterogeneity, impurities, and degradation products). The consortium combines extensive expertise in these fields and has advanced equipment at its disposal to use in this project. Moreover, new technologies and systems will be developed and applied. Funding was approved because the application combines scientific novelty with extensive potential for real-life applications and both these aspects were considered to be excellent.
Last modified: | 22 August 2024 1.29 p.m. |
More news
-
25 April 2025
Leading microbiologist Arnold Driessen honoured
On 25 April 2025, Arnold Driessen (Horst, the Netherlands, 1958) received a Royal Decoration. Driessen is Professor of Molecular Microbiology and chair of the Molecular Microbiology research department of the Faculty of Science and Engineering at the...
-
24 April 2025
Highlighted papers April 2025
The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers.
-
22 April 2025
Microplastics and their effects on the human body
Professor of Respiratory Immunology Barbro Melgert has discovered how microplastics affect the lungs and can explain how to reduce our exposure.